MDXXF (Pharmala Biotech Holdings) Other Current Receivables : $0.02 Mil (As of Feb. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings Other Current Receivables?

Pharmala Biotech Holdings's Other Current Receivables for the quarter that ended in Feb. 2025 was $0.02 Mil.

Pharmala Biotech Holdings's quarterly Other Current Receivables declined from Aug. 2024 ($0.01 Mil) to Nov. 2024 ($0.00 Mil) but then increased from Nov. 2024 ($0.00 Mil) to Feb. 2025 ($0.02 Mil).

Pharmala Biotech Holdings's annual Other Current Receivables increased from Aug. 2022 ($0.02 Mil) to Aug. 2023 ($0.06 Mil) but then declined from Aug. 2023 ($0.06 Mil) to Aug. 2024 ($0.01 Mil).

Pharmala Biotech Holdings Other Current Receivables Historical Data

The historical data trend for Pharmala Biotech Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Other Current Receivables Chart

Pharmala Biotech Holdings Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Other Current Receivables

0.05

0.02

0.06

0.01

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24	Feb25
Other Current Receivables	Get a 7-Day Free Trial										0.12	0.21	0.01	-	0.02

Pharmala Biotech Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Pharmala Biotech Holdings Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

MDMA:Canada

Address

1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9

Website

https://www.pharmala.ca

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.